Brighter in Qatar talking about how data insights can be used to improve diabetes care in the public sector

It was an interesting week for Brighter´s interim CEO Erik Lissner and Head of Sales & Marketing, Johan Möller when visiting its distributor Al Danah, hospitals and other healthcare facilities in Qatar, while the commercialization is getting closer.  

“Besides discussing the Qatar launch we have received positive feedback from endocrinologists believing Actiste®, with its data insights, would be very valuable to their patients. It’s a good indication that we are on the right track and very reassuring as support from healthcare providers is a must to succeed”, says Erik Lissner. 

The team also met the Swedish ambassador who is happy to assist in different business-related projects and matters.

More information will follow as the company is taking the final steps towards its commercialization in Qatar.

For further information, please contact:
Investor Relations
ir@brighter.se

Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB,
+46 (0)8 - 684 211 10
adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones, and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at https://brighter.se/.